Literature DB >> 15489944

Blasts from the past.

Paul A Insel, Stuart Kornfeld, Philip W Majerus, Andrew R Marks, Paul A Marks, Arnold S Relman, Bruce F Scharschmidt, Thomas P Stossel, Ajit P Varki, Stephen J Weiss, Jean D Wilson.   

Abstract

With this issue of the JCI, we celebrate the 80th anniversary of the Journal. While 80 years is not a century, we still feel it is important to honor what the JCI has meant to the biomedical research community for 8 decades. To illustrate why the JCI is the leading general-interest translational research journal edited by and for biomedical researchers, we have asked former JCI editors-in-chief to reflect on some of the major scientific advances reported in the pages of the Journal during their tenures.

Mesh:

Year:  2004        PMID: 15489944      PMCID: PMC522273          DOI: 10.1172/JCI23321

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  107 in total

Review 1.  Adipocyte biology and adipocytokines.

Authors:  Wasim A Haque; Abhimanyu Garg
Journal:  Clin Lab Med       Date:  2004-03       Impact factor: 1.935

2.  The effect of epinephrine on immunoreactive insulin levels in man.

Authors:  D Porte; A L Graber; T Kuzuya; R H Williams
Journal:  J Clin Invest       Date:  1966-02       Impact factor: 14.808

3.  PADGEM protein: a receptor that mediates the interaction of activated platelets with neutrophils and monocytes.

Authors:  E Larsen; A Celi; G E Gilbert; B C Furie; J K Erban; R Bonfanti; D D Wagner; B Furie
Journal:  Cell       Date:  1989-10-20       Impact factor: 41.582

Review 4.  Targeting death receptors in cancer with Apo2L/TRAIL.

Authors:  Sean K Kelley; Avi Ashkenazi
Journal:  Curr Opin Pharmacol       Date:  2004-08       Impact factor: 5.547

5.  Endothelial and nonendothelial sources of PDGF-B regulate pericyte recruitment and influence vascular pattern formation in tumors.

Authors:  Alexandra Abramsson; Per Lindblom; Christer Betsholtz
Journal:  J Clin Invest       Date:  2003-10       Impact factor: 14.808

6.  Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer.

Authors:  Herbert Hurwitz; Louis Fehrenbacher; William Novotny; Thomas Cartwright; John Hainsworth; William Heim; Jordan Berlin; Ari Baron; Susan Griffing; Eric Holmgren; Napoleone Ferrara; Gwen Fyfe; Beth Rogers; Robert Ross; Fairooz Kabbinavar
Journal:  N Engl J Med       Date:  2004-06-03       Impact factor: 91.245

7.  Alzheimer disease risk and genetic variation in ACE: a meta-analysis.

Authors:  Jacob S Elkins; Vanja C Douglas; S Claiborne Johnston
Journal:  Neurology       Date:  2004-02-10       Impact factor: 9.910

Review 8.  Update on adipocyte hormones: regulation of energy balance and carbohydrate/lipid metabolism.

Authors:  Peter J Havel
Journal:  Diabetes       Date:  2004-02       Impact factor: 9.461

9.  Evidence for the presence of oxidatively modified low density lipoprotein in atherosclerotic lesions of rabbit and man.

Authors:  S Ylä-Herttuala; W Palinski; M E Rosenfeld; S Parthasarathy; T E Carew; S Butler; J L Witztum; D Steinberg
Journal:  J Clin Invest       Date:  1989-10       Impact factor: 14.808

Review 10.  Leptin: a multifaceted hormone in the central nervous system.

Authors:  Jenni Harvey
Journal:  Mol Neurobiol       Date:  2003-12       Impact factor: 5.590

View more
  1 in total

1.  Evaluation of C-reactive protein, endothelin-1, adhesion molecule(s), and lipids as inflammatory markers in type 2 diabetes mellitus patients.

Authors:  Hala el-Mesallamy; Salwa Suwailem; Nadia Hamdy
Journal:  Mediators Inflamm       Date:  2007-02-25       Impact factor: 4.711

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.